PERCEPTIVE ADVISORS LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001224962

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2025 · 84 positions · Total reported value $2.69B · Top-10 concentration 54.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.5% · 26 new · 28 cut · 12 exited

Active Share (vs S&P 500): 98.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +23.3% · vs SPY +8.4% · Prev Value $4.76B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, PERCEPTIVE ADVISORS LLC disclosed 84 equity positions with a combined reported value of $2.69B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were VRNA ($520.91M), ASND ($166.37M), ACLX ($163.18M). By sector, the heaviest allocations are Health Care 59.1%, Industrials 0.3%. Versus the prior quarter, allocation shifted toward Health Care (+8.8pp) and away from Other (-8.4pp).

Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 26 new positions, trimmed 28 and fully exited 12, a turnover rate of 55.5% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q2 2025 were ASND ($166.37M), OMDA ($44.40M), ROIV ($37.55M).

Of the 12 positions fully exited versus the prior quarter, the largest were ITCI ($103.74M), IOVA ($42.33M), ARGX ($35.22M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • ASND ASCENDIS PHARMA A/S · $166.37M
  • OMDA OMADA HEALTH INC · $44.40M
  • ROIV ROIVANT SCIENCES LTD · $37.55M
  • CAI CARIS LIFE SCIENCES INC · $29.34M
  • XBI SPDR SERIES TRUST · $24.88M
  • CTMX CYTOMX THERAPEUTICS INC. · $15.88M
  • CRL CHARLES RIV LABS INTL INC · $15.17M
  • TVTX TRAVERE THERAPEUTICS INC · $12.35M

Fully Exited (vs previous quarter)

  • ITCI INTRA-CELLULAR THERAPIES INC · prev qtr: $103.74M
  • IOVA IOVANCE BIOTHERAPEUTICS · prev qtr: $42.33M
  • ARGX ARGENX SE · prev qtr: $35.22M
  • PCVX VAXCYTE INC · prev qtr: $26.68M
  • MDGL MADRIGAL PHARMACEUTICALS INC · prev qtr: $15.40M
  • DXCM DEXCOM INC · prev qtr: $12.16M
  • ACRV ACRIVON THERAPEUTICS INC · prev qtr: $10.88M
  • CRGX CARGO THERAPEUTICS INC · prev qtr: $9.89M

Insider Transactions (Form 4)

Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Opt exercise LeonaBio, Inc. 776,648 $0.00 SEC filing
2026-08-26 Buy Immatics N.V. 863,060 $8.69 SEC filing
2026-07-20 Award Freenome, Inc. 5,500,000 $10.00 SEC filing
2026-06-17 Award Kardigan, Inc. 20,706 — SEC filing
2026-04-17 Award MeiraGTx Holdings plc 555,555 $9.00 SEC filing

All insider transactions →

Fund Profile

Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 107 US equity positions with a combined value of $6.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-71841 (status: Approved), registered 2010-10-04
  • Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 17 private funds, of which 6 hedge funds

Portfolio Structure

  • 107 positions · $6.30B reported value (Q2 2026)
  • Top 10 holdings = 47.5% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 10.8%
  • Average position size: $58.91M

Sector Tilt

  • Health Care 89.0%
  • Industrials 1.2%
  • Financials 0.1%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 26 new, 28 added, 28 reduced, 12 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 59.1%
Other 40.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 5.51M $520.91M 19.36%
19.36%
Reduce
2 963.89K $166.37M 6.18%
6.18%
New
3 2.48M $163.18M 6.06%
6.06%
Reduce
4 2.42M $152.81M 5.68%
5.68%
Reduce
5 1.38M $104.93M 3.90%
3.90%
Reduce
6 2.79M $86.88M 3.23%
3.23%
Hold
7 12.63M $82.23M 3.06%
3.06%
Hold
8 650.25K $65.44M 2.43%
2.43%
Add
9 4.64M $60.83M 2.26%
2.26%
Add
10 1.07M $59.38M 2.21%
2.21%
Reduce
11 11.91M $57.99M 2.15%
2.15%
Hold
12 1.18M $51.34M 1.91%
1.91%
Add
13 7.90M $50.65M 1.88%
1.88%
Hold
14 9.38M $50.48M 1.88%
1.88%
Hold
15 915.89K $48.87M 1.82%
1.82%
Add
16 2.43M $44.40M 1.65%
1.65%
New
17 7.41M $42.48M 1.58%
1.58%
Reduce
18 3.33M $37.55M 1.40%
1.40%
New
19 708.18K $37.25M 1.38%
1.38%
Add
20 430.44K $36.06M 1.34%
1.34%
Reduce
21 6.49M $34.76M 1.29%
1.29%
Hold
22 2.14M $34.21M 1.27%
1.27%
Reduce
23 255.05K $32.06M 1.19%
1.19%
Add
24 752.92K $31.66M 1.18%
1.18%
Reduce
25 280.00K $30.07M 1.12%
1.12%
Add
26 1.10M $29.34M 1.09%
1.09%
New
27 300.00K $24.88M 0.93%
0.93%
New
28 45.12K $24.52M 0.91%
0.91%
Add
29 1.30M $23.74M 0.88%
0.88%
Reduce
30 1.59M $23.20M 0.86%
0.86%
Hold
31 1.53M $22.90M 0.85%
0.85%
Reduce
32 2.47M $22.79M 0.85%
0.85%
Reduce
33 1.63M $21.80M 0.81%
0.81%
Reduce
34 2.25M $21.40M 0.80%
0.80%
Reduce
35 1.22M $21.10M 0.78%
0.78%
Reduce
36 198.53K $20.72M 0.77%
0.77%
Reduce
37 166.00K $20.65M 0.77%
0.77%
Add
38 60.39K $18.97M 0.70%
0.70%
Reduce
39 833.33K $16.01M 0.59%
0.59%
Hold
40 1.28M $16.00M 0.59%
0.59%
Reduce
41 6.99M $15.88M 0.59%
0.59%
New
42 4.05M $15.52M 0.58%
0.58%
Reduce
43 100.00K $15.17M 0.56%
0.56%
New
44 1.15M $15.07M 0.56%
0.56%
Reduce
45 977.89K $13.95M 0.52%
0.52%
Reduce
46 9.88M $12.84M 0.48%
0.48%
Add
47 1.10M $12.49M 0.46%
0.46%
Add
48 834.25K $12.35M 0.46%
0.46%
New
49 4.59M $12.31M 0.46%
0.46%
Hold
50 420.69K $10.98M 0.41%
0.41%
Reduce

FAQ

What did PERCEPTIVE ADVISORS LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, PERCEPTIVE ADVISORS LLC reported 84 equity positions worth $2.69B in aggregate; its largest disclosed positions were VRNA ($520.91M), ASND ($166.37M), ACLX ($163.18M).

How large is PERCEPTIVE ADVISORS LLC's portfolio?

PERCEPTIVE ADVISORS LLC reported $2.69B of long equity holdings across 84 positions as of 2025-Q2. Top-10 holdings account for 54.4% of reported value.

What is PERCEPTIVE ADVISORS LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/perceptive-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →